Literature DB >> 11570721

The beta-thalassemia mutation spectrum in the Iranian population.

H Najmabadi1, R Karimi-Nejad, S Sahebjam, F Pourfarzad, S Teimourian, F Sahebjam, N Amirizadeh, M H Karimi-Nejad.   

Abstract

Beta-thalassemia is the most common hereditary disease in Iran. More than two million carriers of beta-thalassemia live in Iran. Since the Iranian population is a mixture of different ethnic groups, it is necessary to determine the frequency and distribution of mutations in the different parts of the country. For this purpose, we divided Iran in to eight different regions according to the geographic and ethnic distribution of the population. Over a 10-year period 1,217 beta-thalassemia chromosomes of 164 affected patients and 889 unrelated carriers were studied using the amplification refractory mutation system-polymerase chain reaction technique. We detected 81% beta-thalassemia mutations in the studied chromosomes. IVS-II-I (G --> A) was the predominant mutation found in our study (34%). Its relative frequency in the north was much higher than other regions, and it lessened toward the south, where the IVS-I-5 (G --> C) mutation was more common. IVS-I-5 (G --> C) (7.55%), codons 8/9 (+ G) (4.76%), and IVS-I-110 (G --> A) (4.76%) were the other most common mutations. The results presented here can be used as a basis of prenatal diagnosis of beta-thalassemia in different regions of Iran.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11570721     DOI: 10.1081/hem-100105221

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  39 in total

1.  Iranian national thalassaemia screening programme.

Authors:  Ashraf Samavat; Bernadette Modell
Journal:  BMJ       Date:  2004-11-13

2.  Molecular epidemiology of β-thalassemia in Pakistan: far reaching implications.

Authors:  Saqib H Ansari; Tahir S Shamsi; Mushtaq Ashraf; Muneera Bohray; Tasneem Farzana; Mohammed Tahir Khan; Kousar Perveen; Sajida Erum; Iqra Ansari; Muhammad Nadeem; Masood Ahmed; Faizan Raza
Journal:  Int J Mol Epidemiol Genet       Date:  2011-11-28

3.  Hb Knossos: HBB:c.82G>T Associated with HBB:c.315+1G>A Beta Zero Mutation Causes Thalassemia Intermedia.

Authors:  Hengameh Nasouhipur; Ali Banihashemi; Reza Youssefi Kamangar; Haleh Akhavan-Niaki
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-31       Impact factor: 0.900

4.  Epidemiological profile of common haemoglobinopathies in Arab countries.

Authors:  Hanan A Hamamy; Nasir A S Al-Allawi
Journal:  J Community Genet       Date:  2012-12-08

5.  Molecular Characterization of β-Thalassemia in Nineveh Province Illustrates the Relative Heterogeneity of Mutation Distributions in Northern Iraq.

Authors:  Adil A Eissa; Muna A Kashmoola; Sulav D Atroshi; Nasir A S Al-Allawi
Journal:  Indian J Hematol Blood Transfus       Date:  2014-04-02       Impact factor: 0.900

6.  Molecular characterization of β-thalassemia intermedia: a report from Iran.

Authors:  Aida Arab; Morteza Karimipoor; Ali Rajabi; Mohammad Hamid; Sedeigheh Arjmandi; Sirous Zeinali
Journal:  Mol Biol Rep       Date:  2010-12-01       Impact factor: 2.316

7.  The Xmn1 polymorphic site 5' to the (G)gamma gene and its correlation to the (G)gamma:(A)gamma ratio, age at first blood transfusion and clinical features in beta-thalassemia patients from Western Iran.

Authors:  Hooshang Nemati; Zohreh Rahimi; Gholamreza Bahrami
Journal:  Mol Biol Rep       Date:  2009-05-15       Impact factor: 2.316

8.  Prevalence of common MEFV mutations and carrier frequencies in a large cohort of Iranian populations.

Authors:  Maryam Beheshtian; Nasim Izadi; Gernot Kriegshauser; Kimia Kahrizi; Elham Parsi Mehr; Maryam Rostami; Masoumeh Hosseini; Maryam Azad; Mona Montajabiniat; Ariana Kariminejad; Stefan Nemeth; Christian Oberkanins; Hossein Najmabadi
Journal:  J Genet       Date:  2016-09       Impact factor: 1.166

9.  Hydroxyurea responsiveness in β-thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity.

Authors:  Farzin Pourfarzad; Marieke von Lindern; Azita Azarkeivan; Jun Hou; Sima Kheradmand Kia; Fatemehsadat Esteghamat; Wilfred van Ijcken; Sjaak Philipsen; Hossein Najmabadi; Frank Grosveld
Journal:  Haematologica       Date:  2012-10-25       Impact factor: 9.941

10.  Detection of responsible mutations for beta thalassemia in the Kermanshah Province of Iran using PCR-based techniques.

Authors:  Zohreh Rahimi; Adriana Muniz; Abbas Parsian
Journal:  Mol Biol Rep       Date:  2009-05-13       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.